Unity Biotechnology, Inc. (UBX)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Unity Biotechnology, Inc. (UBX)
Company Performance

Current Price

as of Oct 11, 2024

$1.50

P/E Ratio

N/A

Market Cap

$24.6M

Description

Unity Biotechnology, Inc. operates as a biotechnology company. The firm is developing a portfolio of programs like biological mechanisms implicated in diseases of aging, and also senolytic programs in ophthalmologic and neurologic disorders. The company was founded by Nathaniel Eames David, Jan van Deursen, Judith Campisi, and Daohong Zhou on March 30, 2009 and is headquartered in South San Francisco, CA.

Metrics

Overview

  • HQSouth San Francisco, CA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerUBX
  • Price$1.5+2.74%

Trading Information

  • Market Cap$24.60M
  • Float91.19%
  • Average Daily Volume (1m)29,377
  • Average Daily Volume (3m)38,154
  • EPS-$1.98

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$5.28M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$9.96M
  • EV$10.38M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B1.25
Documents